Classification and Pathology of Lung Cancer
- PMID: 27261908
- DOI: 10.1016/j.soc.2016.02.003
Classification and Pathology of Lung Cancer
Abstract
Advancement in the understanding of lung tumor biology enables continued refinement of lung cancer classification, reflected in the recently introduced 2015 World Health Organization classification of lung cancer. In small biopsy or cytology specimens, special emphasis is placed on separating adenocarcinomas from the other lung cancers to effectively select tumors for targeted molecular testing. In resection specimens, adenocarcinomas are further classified based on architectural pattern to delineate tissue types of prognostic significance. Neuroendocrine tumors are divided into typical carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma based on a combination of features, especially tumor cell proliferation rate.
Keywords: Classification; Immunohistochemistry; Lung cancer; Molecular testing; Pathology.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Small Biopsy and Cytology of Pulmonary Neuroendocrine Neoplasms: Brief Overview of Classification, Immunohistochemistry, Molecular Profiles, and World Health Organization Updates.Adv Anat Pathol. 2022 Nov 1;29(6):329-336. doi: 10.1097/PAP.0000000000000360. Epub 2022 Sep 2. Adv Anat Pathol. 2022. PMID: 36053019 Review.
-
Clinical implications of lung neuroendocrine neoplasm classification.Expert Rev Anticancer Ther. 2021 Apr;21(4):377-387. doi: 10.1080/14737140.2021.1862654. Epub 2020 Dec 24. Expert Rev Anticancer Ther. 2021. PMID: 33306420 Review.
-
Two cases of lung neuroendocrine carcinoma with carcinoid morphology.Diagn Pathol. 2019 Sep 12;14(1):104. doi: 10.1186/s13000-019-0886-1. Diagn Pathol. 2019. PMID: 31511024 Free PMC article.
-
[Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].Pathologe. 2015 May;36(3):283-92. doi: 10.1007/s00292-015-0030-2. Pathologe. 2015. PMID: 25956813 Review. German.
-
Bronchopulmonary carcinoid tumors--a significant diagnostic problem.Rocz Akad Med Bialymst. 1997;42 Suppl 1:146-61. Rocz Akad Med Bialymst. 1997. PMID: 9337533 Review.
Cited by
-
Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells.Int J Oncol. 2024 Nov;65(5):102. doi: 10.3892/ijo.2024.5690. Epub 2024 Sep 20. Int J Oncol. 2024. PMID: 39301639 Free PMC article.
-
Expression and Function of Eicosanoid-Producing Cytochrome P450 Enzymes in Solid Tumors.Front Pharmacol. 2020 Jun 9;11:828. doi: 10.3389/fphar.2020.00828. eCollection 2020. Front Pharmacol. 2020. PMID: 32581794 Free PMC article. Review.
-
Reduced circulating exosomal miR-382 predicts unfavorable outcome in non-small cell lung cancer.Int J Clin Exp Pathol. 2021 Apr 15;14(4):469-474. eCollection 2021. Int J Clin Exp Pathol. 2021. PMID: 33936369 Free PMC article.
-
Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems.Curr Oncol. 2023 Jan 5;30(1):704-719. doi: 10.3390/curroncol30010055. Curr Oncol. 2023. PMID: 36661704 Free PMC article. Review.
-
State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent.Cancers (Basel). 2022 Feb 21;14(4):1089. doi: 10.3390/cancers14041089. Cancers (Basel). 2022. PMID: 35205836 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
